Beth E. Meyerson

1.5k total citations
78 papers, 1.0k citations indexed

About

Beth E. Meyerson is a scholar working on Epidemiology, Infectious Diseases and General Health Professions. According to data from OpenAlex, Beth E. Meyerson has authored 78 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Epidemiology, 26 papers in Infectious Diseases and 26 papers in General Health Professions. Recurrent topics in Beth E. Meyerson's work include HIV, Drug Use, Sexual Risk (28 papers), HIV/AIDS Research and Interventions (25 papers) and Opioid Use Disorder Treatment (21 papers). Beth E. Meyerson is often cited by papers focused on HIV, Drug Use, Sexual Risk (28 papers), HIV/AIDS Research and Interventions (25 papers) and Opioid Use Disorder Treatment (21 papers). Beth E. Meyerson collaborates with scholars based in United States, Russia and Australia. Beth E. Meyerson's co-authors include Jon Agley, Priscilla T. Ryder, Richard A. Crosby, Lori Ann Eldridge, William L. Yarber, Christiana von Hippel, Wasantha Jayawardene, Kelsey C. Coy, Alissa Davis and Ruth A. Gassman and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and American Journal of Public Health.

In The Last Decade

Beth E. Meyerson

74 papers receiving 953 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Beth E. Meyerson United States 20 565 380 317 276 139 78 1.0k
Margaret Pereyra United States 24 772 1.4× 332 0.9× 685 2.2× 439 1.6× 62 0.4× 56 1.5k
Ellen Childs United States 15 638 1.1× 326 0.9× 379 1.2× 264 1.0× 34 0.2× 36 1.1k
Simeon D. Kimmel United States 17 564 1.0× 510 1.3× 236 0.7× 192 0.7× 70 0.5× 53 938
Dea L. Biancarelli United States 16 799 1.4× 314 0.8× 460 1.5× 275 1.0× 24 0.2× 24 1.1k
Alissa Davis United States 14 297 0.5× 152 0.4× 201 0.6× 140 0.5× 44 0.3× 57 604
Jeffrey Bratberg United States 22 700 1.2× 1.0k 2.7× 142 0.4× 219 0.8× 377 2.7× 97 1.5k
Silvia Amesty United States 13 381 0.7× 138 0.4× 317 1.0× 187 0.7× 37 0.3× 29 597
Jeff Taylor United States 24 212 0.4× 436 1.1× 547 1.7× 381 1.4× 369 2.7× 107 1.4k
Alexei Zelenev United States 19 824 1.5× 303 0.8× 465 1.5× 237 0.9× 25 0.2× 34 1.0k
Ramesh Holla India 17 306 0.5× 202 0.5× 275 0.9× 155 0.6× 106 0.8× 98 1.1k

Countries citing papers authored by Beth E. Meyerson

Since Specialization
Citations

This map shows the geographic impact of Beth E. Meyerson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beth E. Meyerson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beth E. Meyerson more than expected).

Fields of papers citing papers by Beth E. Meyerson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beth E. Meyerson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beth E. Meyerson. The network helps show where Beth E. Meyerson may publish in the future.

Co-authorship network of co-authors of Beth E. Meyerson

This figure shows the co-authorship network connecting the top 25 collaborators of Beth E. Meyerson. A scholar is included among the top collaborators of Beth E. Meyerson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beth E. Meyerson. Beth E. Meyerson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meyerson, Beth E., Sergio Richter, Ross Gordon, et al.. (2025). Pharmacy harm reduction practices to help reduce opioid overdoses, Arizona 2023. Journal of the American Pharmacists Association. 65(3). 102348–102348.
2.
Meyerson, Beth E., et al.. (2024). Dialing for doctors: Secret shopper study of Arizona methadone and buprenorphine providers, 2022. Journal of Substance Use and Addiction Treatment. 160. 209306–209306. 4 indexed citations
3.
Meyerson, Beth E., Jon Agley, Richard A. Crosby, et al.. (2024). Come back when you’re infected: pharmacy access to sterile syringes in an Arizona Secret Shopper Study, 2023. Harm Reduction Journal. 21(1). 49–49. 9 indexed citations
4.
Eldridge, Lori Ann, Beth E. Meyerson, & Jon Agley. (2024). Implementation Documentation and Process Assessment of the PharmNet Intervention: Observational Report. JMIR Formative Research. 8. e54077–e54077. 1 indexed citations
5.
Wallace, Jessica, et al.. (2024). The unmet mental health needs of U.S. adults living with chronic pain. Pain. 165(12). 2877–2887. 6 indexed citations
6.
Frank, David, Alex S. Bennett, Charles M. Cleland, et al.. (2024). “I still can feel the sickness”: Withdrawal experiences of people on methadone maintenance treatment. Journal of Substance Use and Addiction Treatment. 170. 209616–209616.
7.
Meyerson, Beth E., Jon Agley, Richard A. Crosby, et al.. (2024). ASAP: A pharmacy-level intervention to increase nonprescription syringe sales to reduce bloodborne illnesses. Research in Social and Administrative Pharmacy. 20(8). 778–785. 2 indexed citations
8.
Frank, David, Luther Elliott, Charles M. Cleland, et al.. (2023). “As safe as possible”: a qualitative study of opioid withdrawal and risk behavior among people who use illegal opioids. Harm Reduction Journal. 20(1). 158–158. 18 indexed citations
9.
Meyerson, Beth E., et al.. (2022). Nothing really changed: Arizona patient experience of methadone and buprenorphine access during COVID. PLoS ONE. 17(10). e0274094–e0274094. 19 indexed citations
10.
Meyerson, Beth E., et al.. (2022). Opportunities and Challenges: Hepatitis C Testing and Treatment Access Experiences Among People in Methadone and Buprenorphine Treatment During COVID-19, Arizona, 2021. SHILAP Revista de lepidopterología. 2(1). 100047–100047. 3 indexed citations
11.
Exten, Cara, Casey N. Pinto, Anne M. Gaynor, et al.. (2021). Direct-to-Consumer Sexually Transmitted Infection Testing Services: A Position Statement from the American Sexually Transmitted Diseases Association. Sexually Transmitted Diseases. 48(11). e155–e159. 26 indexed citations
12.
Meyerson, Beth E., et al.. (2021). I don't even want to go to the doctor when I get sick now: Healthcare experiences and discrimination reported by people who use drugs, Arizona 2019. International Journal of Drug Policy. 93. 103112–103112. 63 indexed citations
13.
Meyerson, Beth E., et al.. (2019). State statutes and regulations related to human papillomavirus vaccination. Human Vaccines & Immunotherapeutics. 15(7-8). 1519–1526. 21 indexed citations
14.
Meyerson, Beth E., Jon Agley, Alissa Davis, et al.. (2018). Predicting pharmacy naloxone stocking and dispensing following a statewide standing order, Indiana 2016. Drug and Alcohol Dependence. 188. 187–192. 77 indexed citations
15.
Meyerson, Beth E., et al.. (2017). Against the Odds: Syringe Exchange Policy Implementation in Indiana. AIDS and Behavior. 21(4). 973–981. 13 indexed citations
16.
17.
Meyerson, Beth E., et al.. (2016). Expanding HIV Testing in African American Communities Through Community-Based Distribution of Home-Test Vouchers. AIDS Patient Care and STDs. 30(3). 141–145. 8 indexed citations
18.
Meyerson, Beth E., et al.. (2016). It’s Not Just a Yes or No Answer: Expressions of Local Health Department Accreditation. Frontiers in Public Health. 4. 21–21. 5 indexed citations
19.
Meyerson, Beth E., et al.. (2013). Institutional and Structural Barriers to HIV Testing: Elements for a Theoretical Framework. AIDS Patient Care and STDs. 28(1). 22–27. 23 indexed citations
20.
Crosby, Richard A., Sara K. Head, Ralph J. DiClemente, Beth E. Meyerson, & Adewale Troutman. (2008). Do Protective Behaviors Follow the Experience of Testing Positive for Herpes Simplex Type 2?. Sexually Transmitted Diseases. 35(9). 787–790. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Margaret Pereyra Breakdown of academic impact, for papers by Ellen Childs Breakdown of academic impact, for papers by Simeon D. Kimmel Breakdown of academic impact, for papers by Dea L. Biancarelli Breakdown of academic impact, for papers by Alissa Davis Breakdown of academic impact, for papers by Jeffrey Bratberg Breakdown of academic impact, for papers by Silvia Amesty Breakdown of academic impact, for papers by Jeff Taylor Breakdown of academic impact, for papers by Alexei Zelenev Breakdown of academic impact, for papers by Ramesh Holla
Rankless by CCL
2026